One man's lung cancer with a missing SMARCA4 gene
Original title: Advanced non-small cell lung cancer with SMARCA4 deficiency: a case report.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report on one patient, not a trial that tested the treatment.
The short version
Doctors report on one man whose rare lung cancer shrank fast with chemo, but later spread to his brain.
What was studied. This is a case report about one person. He was a 49-year-old man with stage IV lung cancer that lacked the SMARCA4 gene. Doctors gave him nab-Paclitaxel, cisplatin, and bevacizumab.
What they found. His cancer responded fast to this drug mix. But the cancer later spread to his brain and kept growing. He lived about 12 months in all.
What this means, and what it doesn't
What it could mean: Some people with this rare lung cancer may get some help from chemo plus a drug that blocks blood vessel growth. There is no set treatment plan for this cancer yet. The outlook is still poor.
What it doesn't mean: This is one person's story, not a study of many people. One case cannot show that a treatment works. It is not a new treatment, and it is not a cure. Talk with your own doctor about what fits your case.
Source: PubMed, August 10, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.